Page 23 - Ayurvedic Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Antiviral drug 'Clevira' repurposed for treating mild to moderate COVID-19 patients The drug is effective when taken orally and the dosage is one tablet twice daily after food for 14 days. Share Via Email   |  A+A A- Beds lie inside an indoor stadium converted into COVID-19 treatment center for emergencies in the wake of the spike in the numbers of positive coronavirus cases in Srinagar. (Photo | AP) By PTI NEW DELHI: Clevira, a drug primarily developed to treat dengue, has been repurposed as supportive treatment for mild to moderate COVID-19 cases, its manufacturer Apex Laboratories ...

Share Bhubaneswar: Apex Laboratories Private Limited, a Chennai based pharmaceutical company known for its cutting-edge research and innovation, introduces Clevira, an antiviral herbal formulation. Clevira was developed primarily to treat dengue patients in 2017. Last year as the COVID-19 cases surged in the country, it was repurposed as supportive treatment for mild to moderate COVID symptoms. The product is available across India and is priced at Rs 11 per tablet. A clinical trial was conducted on 100 people in May-June 2020 and the results were promising. During the 30 days trial, conducte...

Poly herbal drug Ayush 64 is useful in mild to moderate Covid cases April 30, 2021 Originally developed for treating malaria in 1980, it is now repurposed to treat Covid-19 Ayush 64, a poly herbal formulation developed by the Central Council for Research in Ayurvedic Sciences (CCRAS), could be effective in treating asymptomatic, mild and moderate Covid-19 infection if it is used as an adjunct to standard care, a statement from Ayush Ministry said on Thursday. The herbal drug, developed for treating malaria in 1980, but now repurposed to treat Covid-19 is found to be effective in studies c...

Ayush Ministry has said that scientists have found that ayurvedic medicine AYUSH 64 is also proving useful in the treatment of asymptomatic, mild and moderate COVID-19 infection as an adjunct to standard care.

Poly Herbal Formulation AYUSH-64 Found Useful In Treatment Of Mild To Moderate COVID-19 Infection: AYUSH Ministry by Swarajya Staff - Apr 29, 2021 11:52 AM AYUSH-64 (Pic Via Twitter) The scientists of reputed research institutions of the country have found that AYUSH 64, a poly herbal formulation developed by the Central Council for Research in Ayurvedic Sciences (CCRAS) under the Ministry of Ayush, is useful in the treatment of asymptomatic, mild and moderate COVID-19 infection as an adjunct to standard care, an official release said on Thursday (29 April). The drug was developed in 1980 for...